MAPT and Alzheimer disease: The anti-inflammatory activity of quercetin has also been thought to underlie its positive effect on cognitive function in APP/PS1 mouse model of AD, where it also reduces Aβ plaques and Tau phosphorylation (Lv et al., 2018).